Mouse Anti-DEPDC1 Recombinant Antibody (6H1) (CBMAB-A2187-LY)

Wang, Q., Jiang, S., Liu, J., Ma, G., Zheng, J., & Zhang, Y. (2021). DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial–Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12. Cancer Biotherapy & Radiopharmaceuticals, 36(1), 36-44.

Li, Y. Y., Li, W., Chang, G. Z., & Li, Y. M. (2021). Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial–mesenchymal transition. Anti-Cancer Drugs, 32(6), 614-625.

Shen, X., & Han, J. (2020). Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer. Journal of Clinical Laboratory Analysis, 34(12), e23634.

Guo, W., Li, H., Liu, H., Ma, X., Yang, S., & Wang, Z. (2019). DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway. Oncology reports, 42(3), 1075-1089.

Qu, D., Cui, F., Lu, D., Yang, Y., & Xu, Y. (2019). DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis. Cancer Science, 110(1), 157-165.

Hao, S., Tian, W., Chen, Y., Wang, L., Jiang, Y., Gao, B., & Luo, D. (2019). MicroRNA‐374c‐5p inhibits the development of breast cancer through TATA‐box binding protein associated factor 7‐mediated transcriptional regulation of DEP domain containing 1. Journal of cellular biochemistry, 120(9), 15360-15368.

Zhao, H., Yu, M., Sui, L., Gong, B., Zhou, B., Chen, J., ... & Hao, C. (2019). High expression of DEPDC1 promotes malignant phenotypes of breast cancer cells and predicts poor prognosis in patients with breast cancer. Frontiers in oncology, 9, 262.

Li, A., Wang, Q., He, G., Jin, J., & Huang, G. (2018). DEP domain containing 1 suppresses apoptosis via inhibition of A20 expression, which activates the nuclear factor κB signaling pathway in HepG2 cells. Oncology letters, 16(1), 949-955.

Wang, Q., Li, A., Jin, J., & Huang, G. (2017). Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway. OncoTargets and therapy, 10, 4443.

Huang, L., Chen, K., Cai, Z. P., Chen, F. C., Shen, H. Y., Zhao, W. H., ... & Lin, X. (2017). DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer. Biochemical and biophysical research communications, 490(3), 707-712.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols